The purchase price, and that is confidential & was negotiated for a maximum of 300 zillion doses, is a little lower than the $19.50 a photo the United States agreed to purchase a first shipment of hundred million doses of the same vaccine, in line with what Reuters claimed in November.
The EU file dated Nov. 18 was circulated internally after the EU announced the supply package of its with Pfizer and the German partner BioNTech of its on Nov. 11.
The EU drug regulator is expected to determine on Monday on acceptance for the Pfizer vaccine after the shot was authorised in several countries, including Britain and the United States.
On Thursday Belgian say secretary for the budget Eva De Bleeker printed on Twitter a dinner table with price tags Belgium will pay pharmaceutical companies for their COVID 19 vaccines. She retracted the content shortly after publishing.
In that table the Pfizer vaccine was suggested as costing Belgium 12 euros ($14.6) a dose, leading many to believe that has been the entire fee agreed by way of the EU.
Other vaccines in the family table were furthermore shown with prices lower compared to prices disclosed by EU sources.
“There is , obviously , a complete price along with a price upon delivery,” an EU official required in talks with vaccine makers told Reuters when directed to clarify the big difference between the EU and Belgian prices.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality requirements, but pointed to what De Bleeker told the Belgian parliament previous week. In this public hearing, De Beeker said Belgium’s budgeted prices were still partial.
Underneath EU prior purchase deals for COVID-19 vaccines, the bloc agrees initial payments with businesses to secure doses before they are approved. After approvals, EU governments can pay the rest to buy reserved doses.
The EU has not revealed the initial transaction agreed with Pfizer.
But, it said in October which it paid aproximatelly one billion euros inside downpayments to AstraZeneca, Sanofi and Johnson & Johnson for the shots of theirs, with a further 1.45 billion euros budgeted for initial payments to Pfizer BioNTech, Curevac and Moderna.
It has since agreed source deals with all 6 corporations and is negotiating a seventh agreement with Novavax.